AAAAAA

   
Results: 1-8 |
Results: 8
THE REVERSION FORCE OF NITI ORTHODONTIC WIRES IN THE TEMPERATURE DOMAIN 5-DIVIDED-BY-55-DEGREES-C
Authors: AIROLDI G CORSI A FIORENTINI F
Citation: G. Airoldi et al., THE REVERSION FORCE OF NITI ORTHODONTIC WIRES IN THE TEMPERATURE DOMAIN 5-DIVIDED-BY-55-DEGREES-C, Journal de physique. IV, 7(C5), 1997, pp. 591-596
INVOLVEMENT OF CYP2D6 BUT NOT CYP2C19 IN NICERGOLINE METABOLISM IN HUMANS
Authors: BOTTIGER Y DOSTERT P BENEDETTI MS BANI M FIORENTINI F CASATI M POGGESTI I ALM C ALVAN G BERTILSSON L
Citation: Y. Bottiger et al., INVOLVEMENT OF CYP2D6 BUT NOT CYP2C19 IN NICERGOLINE METABOLISM IN HUMANS, British journal of clinical pharmacology, 42(6), 1996, pp. 707-711
COMPARATIVE-EVALUATION OF THE CLINICAL AND MICROBIOLOGICAL EFFICACY OF CO-AMOXICLAV VS CEFIXIME OR CIPROFLOXACIN IN BACTERIAL EXACERBATION OF CHRONIC-BRONCHITIS
Authors: CAZZOLA M VINCIGUERRA A BEGHI GF PAIZIS G GIURA R MADONINI V FIORENTINI F CONSIGLI GF TONNA M CASALINI A LEGNANI D
Citation: M. Cazzola et al., COMPARATIVE-EVALUATION OF THE CLINICAL AND MICROBIOLOGICAL EFFICACY OF CO-AMOXICLAV VS CEFIXIME OR CIPROFLOXACIN IN BACTERIAL EXACERBATION OF CHRONIC-BRONCHITIS, Journal of chemotherapy, 7(5), 1995, pp. 432-441
LACK OF PHARMACOKINETIC INTERACTION BETWEEN THE SELECTIVE DOPAMINE AGONIST CABERGOLINE AND THE MAO-B INHIBITOR SELEGILINE
Authors: DOSTERT P BENEDETTI MS PERSIANI S LACROIX R BOSC M FIORENTINI F DEFFOND D VERNAY D DORDAIN G
Citation: P. Dostert et al., LACK OF PHARMACOKINETIC INTERACTION BETWEEN THE SELECTIVE DOPAMINE AGONIST CABERGOLINE AND THE MAO-B INHIBITOR SELEGILINE, Journal of neural transmission. Supplementum, (45), 1995, pp. 247-257
HIGH-AFFINITY AND SELECTIVITY ON 5-HT(1A) RECEPTOR OF 1-ARYL-4-[1-TETRALIN)ALKYL]PIPERAZINES .2.
Authors: PERRONE R BERARDI F COLABUFO NA LEOPOLDO M TORTORELLA V FIORENTINI F OLGIATI V GHIGLIERI A GOVONI S
Citation: R. Perrone et al., HIGH-AFFINITY AND SELECTIVITY ON 5-HT(1A) RECEPTOR OF 1-ARYL-4-[1-TETRALIN)ALKYL]PIPERAZINES .2., Journal of medicinal chemistry, 38(6), 1995, pp. 942-949
LORNOXICAM VERSUS DICLOFENAC IN RHEUMATOID-ARTHRITIS - A DOUBLE-BLIND, MULTICENTER STUDY
Authors: CARUSO I MONTRONE F BOARI L DAVOLI C BEYENE NB CAPORALI R GANDINI R FUMAGALLI M BARATELLI E BROGGINI M CANESI MB MUSCARA M MANZONI A LOCATI M DINGIANNA E FIORENTINI F
Citation: I. Caruso et al., LORNOXICAM VERSUS DICLOFENAC IN RHEUMATOID-ARTHRITIS - A DOUBLE-BLIND, MULTICENTER STUDY, Advances in therapy, 11(3), 1994, pp. 132-138
MIXED 5-HT1A D-2 ACTIVITY OF A NEW MODEL OF ARYLPIPERAZINES - 1-ARYL-4-[3-(1,2-DIHYDRONAPHTHALEN-4-YL)-N-PROPYL] .1. SYNTHESIS AND STRUCTURE-ACTIVITY-RELATIONSHIPS/
Authors: PERRONE R BERARDI F COLABUFO NA TORTORELLA V FIORENTINI F OLGIATI V VANOTTI E GOVONI S
Citation: R. Perrone et al., MIXED 5-HT1A D-2 ACTIVITY OF A NEW MODEL OF ARYLPIPERAZINES - 1-ARYL-4-[3-(1,2-DIHYDRONAPHTHALEN-4-YL)-N-PROPYL] .1. SYNTHESIS AND STRUCTURE-ACTIVITY-RELATIONSHIPS/, Journal of medicinal chemistry, 37(1), 1994, pp. 99-104
SYNTHESIS OF NOVEL DERIVATIVES OF 1H-IMIDAZO[1,2-B]PYRAZOLE AS POTENTIAL CNS-AGENTS
Authors: VANOTTI E FIORENTINI F VILLA M
Citation: E. Vanotti et al., SYNTHESIS OF NOVEL DERIVATIVES OF 1H-IMIDAZO[1,2-B]PYRAZOLE AS POTENTIAL CNS-AGENTS, Journal of heterocyclic chemistry, 31(4), 1994, pp. 737-743
Risultati: 1-8 |